(ACAD) Acadia Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Acadia Pharmaceuticals | (ACAD) share price targets
Complete technical analysis of Acadia Pharmaceuticals (ACAD) by charts plus indicators, forecast predictions and share price targets for Acadia Pharmaceuticals (ACAD)
Acadia Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-25 View latest technical analysis
10 day averaged volume of Acadia Pharmaceuticals is 1223540
Date | Daily Closing Price | Open | High | Low | Volume |
25 Wed Sep 2024 | 15.32 | 15.86 | 15.86 | 15.24 | 1.488 times |
24 Tue Sep 2024 | 15.84 | 16.29 | 16.34 | 15.29 | 3.184 times |
23 Mon Sep 2024 | 16.29 | 16.53 | 16.55 | 16.21 | 0.764 times |
20 Fri Sep 2024 | 16.53 | 16.41 | 16.59 | 16.18 | 1.247 times |
19 Thu Sep 2024 | 16.42 | 16.70 | 16.81 | 16.34 | 0.639 times |
18 Wed Sep 2024 | 16.33 | 16.29 | 16.73 | 16.08 | 0.716 times |
17 Tue Sep 2024 | 16.26 | 16.32 | 16.43 | 16.06 | 0.679 times |
16 Mon Sep 2024 | 16.14 | 16.33 | 16.45 | 16.12 | 0.541 times |
13 Fri Sep 2024 | 16.32 | 16.06 | 16.35 | 15.87 | 0.702 times |
12 Thu Sep 2024 | 15.95 | 15.96 | 16.10 | 15.59 | 0.607 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 15.4, for a target of 15.8 or 16.18
Share price targets for Acadia Pharmaceuticals (ACAD)
Target Type | Value |
Downside Target | 14.55 |
Downside Target | 15.08 |
Upside Target | 15.76 |
Upside Target | 16.55 |
Upside Target | 16.63 |
Upside Target | 16.81 |
Upside Target | 17.03 |
Upside Target | 17.58 |
Upside Target | 19.42 |
Upside Target | 19.44 |
Intraday share price targets for Acadia Pharmaceuticals (ACAD)
Target Type | Value |
Downside Intraday Target | 14.86 |
Downside Intraday Target | 14.39 |
Upside Intraday Target | 16.17 |
Upside Intraday Target | 17.01 |
Upside Intraday Target | 15.7 |
Weekly technical analysis of Acadia Pharmaceuticals (ACAD)
Date | Weekly Closing Price | Open | High | Low | Volume |
25 Wed Sep 2024 | 15.32 | 16.53 | 16.55 | 15.24 | 1.422 times |
20 Fri Sep 2024 | 16.53 | 16.33 | 16.81 | 16.06 | 0.965 times |
13 Fri Sep 2024 | 16.32 | 15.99 | 16.50 | 15.40 | 1.044 times |
06 Fri Sep 2024 | 16.07 | 16.56 | 17.03 | 15.76 | 5.113 times |
30 Fri Aug 2024 | 16.58 | 16.44 | 16.63 | 16.27 | 0.147 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Acadia Pharmaceuticals (ACAD)
Date | Monthly Closing Price | Open | High | Low | Volume |
25 Wed Sep 2024 | 15.32 | 16.56 | 17.03 | 15.24 | 0.464 times |
30 Fri Aug 2024 | 16.58 | 19.08 | 19.42 | 15.08 | 1.14 times |
31 Wed Jul 2024 | 19.02 | 16.19 | 19.44 | 15.40 | 1.2 times |
28 Fri Jun 2024 | 16.25 | 15.12 | 16.53 | 14.55 | 0.814 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Acadia Pharmaceuticals (ACAD)
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Acadia Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Acadia Pharmaceuticals in short term and the sell signal is strong.
Acadia Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Acadia Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Acadia Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 16.03 and Acadia Pharmaceuticals (ACAD) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Acadia Pharmaceuticals (ACAD) stock. Volume based technical analysis of Acadia Pharmaceuticals (ACAD) stock is negative.
Acadia Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Acadia Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Acadia Pharmaceuticals in short term and the sell signal is strong.
Acadia Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Acadia Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Acadia Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 16.03 and Acadia Pharmaceuticals (ACAD) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Acadia Pharmaceuticals (ACAD) stock. Volume based technical analysis of Acadia Pharmaceuticals (ACAD) stock is negative.
Acadia Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.